Wednesday 6/26 Insider Buying Report: PX, ATHA

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

At P10, a filing with the SEC revealed that on Friday, David M. McCoy bought 20,000 shares of PX, at a cost of $8.21 each, for a total investment of $164,200. P10 is trading trading flat on the day Wednesday. Before this latest buy, McCoy made one other buy in the past year, purchasing $136,247 shares at a cost of $9.73 each.

And on Monday, Kelly A. Romano purchased $100,051 worth of Athira Pharma, purchasing 42,400 shares at a cost of $2.36 a piece. This buy marks the first one filed by Romano in the past twelve months. Athira Pharma is trading up about 3.6% on the day Wednesday. Investors are able to snag ATHA even cheaper than Romano did, with the stock changing hands as low as $2.25 in trading on Wednesday -- that's 4.6% under Romano's purchase price.

Wednesday 6/26 Insider Buying Report: PX, ATHAVIDEO: Wednesday 6/26 Insider Buying Report: PX, ATHA

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.